Cash flow Bio-Rad Laboratories, Inc.

Stocks

BIO

US0905722072

Medical Equipment, Supplies & Distribution

Market Closed - NYSE Other stock markets 01:30:02 25/07/2026 am IST			5-day change	1st Jan Change
314.46 ^USD	-0.61%		+4.48%	+3.79%

01/07	Activist investors make bigger push for campaigns in H1, seek more M&A	RE
03/06	Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM

1fb249c3.h0AHSPnWjoMc1YtNwXm88UhtvoNxmVuZKa7MfP2Eosg.tyZdG82Dzdwlt_IvjkvtxwMl_7M-3w3MWZucFajB7Y_9cEMjz4bFwkiH0g

Published financial data: BIO-RAD LABORATORIES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	292.25Cr	280.22Cr	267.13Cr	256.65Cr	258.32Cr
Total Revenues	292.25Cr	280.22Cr	267.13Cr	256.65Cr	258.32Cr
Cost of Goods Sold, Total	125.69Cr	123.38Cr	124.04Cr	118.76Cr	123.96Cr
Gross Profit	166.57Cr	156.84Cr	143.08Cr	137.89Cr	134.36Cr
Selling General & Admin Expenses, Total	85Cr	82Cr	82Cr	81Cr	82Cr
R&D Expenses	26Cr	26Cr	24Cr	30Cr	26Cr
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	111.15Cr	108.15Cr	106.52Cr	110.99Cr	107.74Cr
Operating Income	55Cr	49Cr	37Cr	27Cr	27Cr
Interest Expense, Total	-15.51L	-3.81Cr	-4.94Cr	-4.89Cr	-4.9Cr
Interest And Investment Income	1.89Cr	5.8Cr	10Cr	8.2Cr	9.55Cr
Net Interest Expenses	1.73Cr	1.99Cr	5.15Cr	3.31Cr	4.65Cr
Currency Exchange Gains (Loss)	-27.53L	2L	73.47L	39L	66L
Other Non Operating Income (Expenses)	4L	-53.26L	48.43L	16L	-3L
EBT, Excl. Unusual Items	57Cr	50Cr	43Cr	31Cr	32Cr
Restructuring Charges	-6.44Cr	-42L	-2.79Cr	-	-4.61Cr
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	493.34Cr	-520.32Cr	-125.16Cr	-265.01Cr	90Cr
Gain (Loss) On Sale Of Assets	-	14L	-	-	-
Asset Writedown	-	-	-	-	-17Cr
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	543.81Cr	-470.43Cr	-85Cr	-234.25Cr	100Cr
Income Tax Expense	119.22Cr	-107.67Cr	-21Cr	-50Cr	24Cr
Earnings From Continuing Operations	424.59Cr	-362.75Cr	-64Cr	-184.42Cr	76Cr
Net Income to Company	424.59Cr	-362.75Cr	-64Cr	-184.42Cr	76Cr
Net Income - (IS)	424.59Cr	-362.75Cr	-64Cr	-184.42Cr	76Cr
Net Income to Common Incl Extra Items	424.59Cr	-362.75Cr	-64Cr	-184.42Cr	76Cr
Net Income to Common Excl. Extra Items	424.59Cr	-362.75Cr	-64Cr	-184.42Cr	76Cr
Per Share Items
Net EPS - Basic	142.33	-121.79	-21.82	-65.36	27.85
Basic EPS - Continuing Operations	142.33	-121.79	-21.82	-65.36	27.85
Basic Weighted Average Shares Outstanding	2.98Cr	2.98Cr	2.92Cr	2.82Cr	2.73Cr
Net EPS - Diluted	140.56	-121.79	-21.82	-65.36	27.85
Diluted EPS - Continuing Operations	140.56	-121.79	-21.82	-65.36	27.85
Diluted Weighted Average Shares Outstanding	3.02Cr	2.98Cr	2.92Cr	2.82Cr	2.73Cr
Normalized Basic EPS	11.92	10.53	9.19	6.81	7.31
Normalized Diluted EPS	11.77	10.53	9.19	6.81	7.31
Supplemental Items
EBITDA	69Cr	62Cr	51Cr	42Cr	43Cr
EBITA	58Cr	51Cr	39Cr	29Cr	29Cr
EBIT	55Cr	49Cr	37Cr	27Cr	27Cr
EBITDAR	74Cr	68Cr	57Cr	49Cr	50Cr
Effective Tax Rate - (Ratio)	21.92	22.89	25.03	21.27	23.67
Current Domestic Taxes	8.16Cr	13Cr	8.58Cr	9.5Cr	4.53Cr
Current Foreign Taxes	3.26Cr	2.41Cr	1.74Cr	2.85Cr	1.77Cr
Total Current Taxes	11Cr	16Cr	10Cr	12Cr	6.3Cr
Deferred Domestic Taxes	105.02Cr	-120.49Cr	-31Cr	-61Cr	19Cr
Deferred Foreign Taxes	3.21Cr	-3.67Cr	-1.52Cr	-2.05Cr	-2.23Cr
Total Deferred Taxes	108.23Cr	-124.16Cr	-32Cr	-63Cr	17Cr
Normalized Net Income	36Cr	31Cr	27Cr	19Cr	20Cr
Interest on Long-Term Debt	8L	8L	7L	7L	7L
Non-Cash Pension Expense	6L	-4L	20L	28L	18L
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	28Cr	26Cr	25Cr	30Cr	28Cr
Net Rental Expense, Total	5.02Cr	5.45Cr	6.34Cr	6.95Cr	6.69Cr
Imputed Operating Lease Interest Expense	27.74L	2.06Cr	1.8Cr	1.96Cr	1.9Cr
Imputed Operating Lease Depreciation	4.74Cr	3.39Cr	4.54Cr	4.99Cr	4.79Cr
Stock-Based Comp., COGS (Total)	49L	54L	61L	65L	63L
Stock-Based Comp., R&D Exp. (Total)	83L	99L	1.13Cr	1.29Cr	1.14Cr
Stock-Based Comp., SG&A Exp. (Total)	3.8Cr	4.56Cr	4.39Cr	4.29Cr	4.03Cr
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	5.12Cr	6.09Cr	6.13Cr	6.23Cr	5.8Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	47Cr	43Cr	40Cr	49Cr	53Cr
Short Term Investments	40Cr	135.65Cr	120.33Cr	117.64Cr	101.09Cr
Total Cash And Short Term Investments	87Cr	179.07Cr	160.71Cr	166.45Cr	154.07Cr
Accounts Receivable, Total	42Cr	49Cr	49Cr	45Cr	46Cr
Other Receivables	22L	1.16Cr	1.19Cr	1.31Cr	1.19Cr
Total Receivables	43Cr	51Cr	50Cr	47Cr	47Cr
Inventory	57Cr	72Cr	78Cr	76Cr	74Cr
Prepaid Expenses	11Cr	12Cr	14Cr	12Cr	14Cr
Restricted Cash	14T	13T	2L	14L	20L
Other Current Assets, Total	1.34Cr	1.76Cr	1.96Cr	1.62Cr	1.38Cr
Total Current Assets	198.91Cr	315.8Cr	304.83Cr	303.03Cr	290.62Cr
Gross Property Plant And Equipment	169.34Cr	168.9Cr	179.04Cr	179.78Cr	197.09Cr
Accumulated Depreciation	-100Cr	-100.94Cr	-106.67Cr	-110.92Cr	-126.1Cr
Net Property Plant And Equipment	70Cr	68Cr	72Cr	69Cr	71Cr
Long-term Investments	1.44TCr	882.97Cr	769.66Cr	483.76Cr	610.25Cr
Goodwill	35Cr	41Cr	41Cr	41Cr	58Cr
Other Intangibles, Total	25Cr	33Cr	32Cr	29Cr	17Cr
Other Long-Term Assets, Total	10Cr	9.58Cr	9.64Cr	10Cr	10Cr
Total Assets	1.78TCr	1.35TCr	1.23TCr	936.41Cr	1.06TCr
Liabilities
Accounts Payable, Total	14Cr	14Cr	14Cr	12Cr	13Cr
Accrued Expenses, Total	31Cr	22Cr	14Cr	12Cr	17Cr
Current Portion of Long-Term Debt	-	-	-	8L	8L
Current Portion of Leases	3.69Cr	3.68Cr	4.09Cr	4.21Cr	3.66Cr
Current Income Taxes Payable	1.03Cr	1.19Cr	3.58Cr	3.12Cr	3.66Cr
Unearned Revenue Current, Total	5.09Cr	5.22Cr	-	-	4.89Cr
Other Current Liabilities	13Cr	12Cr	16Cr	15Cr	9.28Cr
Total Current Liabilities	68Cr	57Cr	52Cr	47Cr	52Cr
Long-Term Debt	14T	118.76Cr	118.94Cr	119.12Cr	119.3Cr
Long-Term Leases	19Cr	16Cr	18Cr	14Cr	15Cr
Unearned Revenue Non Current	-	-	-	-	1.4Cr
Pension & Other Post Retirement Benefits	7.38Cr	4.53Cr	5.95Cr	5.69Cr	4.92Cr
Deferred Tax Liability Non Current	305.91Cr	177.05Cr	147.55Cr	82Cr	105.94Cr
Other Non Current Liabilities	11Cr	15Cr	14Cr	12Cr	14Cr
Total Liabilities	410.87Cr	388.64Cr	355.79Cr	279.48Cr	312.29Cr
Common Stock, Total	3T	3T	3T	-	-
Additional Paid In Capital	44Cr	45Cr	45Cr	46Cr	48Cr
Retained Earnings	1.35TCr	989.82Cr	926.06Cr	741.64Cr	817.63Cr
Treasury Stock	-11Cr	-26Cr	-63Cr	-77Cr	-100.96Cr
Comprehensive Income and Other	-18Cr	-47Cr	-34Cr	-54Cr	-19Cr
Total Common Equity	1.37TCr	961.53Cr	874.11Cr	656.93Cr	745.36Cr
Total Equity	1.37TCr	961.53Cr	874.11Cr	656.93Cr	745.36Cr
Total Liabilities And Equity	1.78TCr	1.35TCr	1.23TCr	936.41Cr	1.06TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.99Cr	2.96Cr	2.85Cr	2.8Cr	2.7Cr
ECS Total Common Shares Outstanding	2.99Cr	2.96Cr	2.85Cr	2.8Cr	2.7Cr
Book Value / Share	456.6	324.89	306.51	234.52	276.16
Tangible Book Value	1.31TCr	887.66Cr	800.7Cr	586.52Cr	669.95Cr
Tangible Book Value Per Share	436.51	299.93	280.77	209.39	248.22
Total Debt	22Cr	138.81Cr	140.54Cr	137.47Cr	138.48Cr
Net Debt	-65Cr	-40Cr	-20Cr	-29Cr	-16Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	7.61Cr	4.68Cr	6.22Cr	5.92Cr	5.76Cr
Debt Equivalent Oper. Leases	40Cr	44Cr	51Cr	56Cr	54Cr
Equity Method Investments, Total	5.91Cr	2.67Cr	3.23Cr	2.79Cr	3.69Cr
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	12Cr	23Cr	23Cr	22Cr	21Cr
Inventories - Work In Process, Total	14Cr	22Cr	25Cr	24Cr	23Cr
Inventories - Finished Goods, Total	31Cr	27Cr	30Cr	29Cr	29Cr
Land - (BS)	2.79Cr	2.78Cr	2.84Cr	2.78Cr	2.89Cr
Buildings, Total	39Cr	39Cr	42Cr	43Cr	45Cr
Machinery, Total	107.48Cr	108.66Cr	114.75Cr	118.32Cr	132.26Cr
Full Time Employees	7.9T	8.2T	8.03T	7.7T	7.45T
Accumulated Allowance for Doubtful Accounts (Supple)	1.51Cr	1.5Cr	1.49Cr	92L	55L

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	424.59Cr	-362.75Cr	-64Cr	-184.42Cr	76Cr
Depreciation & Amortization - CF	11Cr	15Cr	12Cr	13Cr	14Cr
Amortization of Goodwill and Intangible Assets - (CF)	2.84Cr	2.49Cr	2.38Cr	2.12Cr	2.38Cr
Depreciation & Amortization, Total	13Cr	18Cr	15Cr	15Cr	17Cr
(Gain) Loss From Sale Of Asset	-	-14L	-25L	-	-
(Gain) Loss on Sale of Investments - (CF)	-492.54Cr	520.55Cr	125.23Cr	265.68Cr	-89Cr
Asset Writedown & Restructuring Costs	-	-	-	2.95Cr	17Cr
Provision for Credit Losses	-	75L	-	-	14L
Stock-Based Compensation (CF)	5.12Cr	6.09Cr	6.13Cr	6.23Cr	5.8Cr
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	88.19L	-1.78Cr	-1.2Cr	2Cr	-33L
Change In Accounts Receivable	-2.04Cr	-8.74Cr	1.14Cr	1.62Cr	1.96Cr
Change In Inventories	4.61Cr	-16Cr	-4.63Cr	85L	6.89Cr
Change In Accounts Payable	6.99Cr	-9.42Cr	-5.18Cr	-4.09Cr	-1L
Change In Income Taxes	-2.88Cr	-12L	-2.13Cr	2.41Cr	15L
Change In Deferred Taxes	108.23Cr	-124.16Cr	-32Cr	-63Cr	17Cr
Change in Other Net Operating Assets	-69L	-2.68Cr	-22L	-19L	1.2Cr
Cash from Operations	66Cr	19Cr	37Cr	46Cr	53Cr
Capital Expenditure	-12Cr	-11Cr	-16Cr	-17Cr	-16Cr
Sale of Property, Plant, and Equipment	52T	2L	2L	1L	1L
Cash Acquisitions	-13Cr	-10Cr	-	-	-22Cr
Divestitures	-	13.6L	25L	-	-
Sale (Purchase) of Intangible assets	-	-13.75L	-	-2.34Cr	-
Investment in Marketable and Equity Securities, Total	-8.47Cr	-99Cr	17Cr	2.87Cr	19Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-45Cr	-	-	-	-
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-78Cr	-120.76Cr	2.02Cr	-16Cr	-19Cr
Long-Term Debt Issued, Total	-	118.62Cr	-	-	-
Total Debt Issued	-	118.62Cr	-	-	-
Long-Term Debt Repaid, Total	-30.2L	-5L	-5L	-4L	-5L
Total Debt Repaid	-30.2L	-5L	-5L	-4L	-5L
Issuance of Common Stock	2.06Cr	1.76Cr	1.85Cr	1.92Cr	1.58Cr
Repurchase of Common Stock	-7.25Cr	-23Cr	-44Cr	-21Cr	-30Cr
Other Financing Activities, Total	-6L	-48T	-	-3.06Cr	-
Cash from Financing	-5.54Cr	97Cr	-43Cr	-22Cr	-28Cr
Foreign Exchange Rate Adjustments	-1.26Cr	29.81L	3L	92L	-1.69Cr
Miscellaneous Cash Flow Adjustments	-	47T	43T	-	-
Net Change in Cash	-20Cr	-3.66Cr	-3.02Cr	8.54Cr	4.24Cr
Supplemental Items
Cash Income Tax Paid (Refund)	13Cr	16Cr	13Cr	9.94Cr	6.16Cr
Levered Free Cash Flow	49Cr	4.56Cr	12Cr	18Cr	26Cr
Unlevered Free Cash Flow	49Cr	6.94Cr	16Cr	21Cr	29Cr
Change In Net Working Capital	-8.03Cr	36Cr	12Cr	-1.84Cr	-5.5Cr
Net Debt Issued / Repaid	-30.2L	118.57Cr	-5L	-4L	-5L

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.25	1.94	1.77	1.55	1.67
Return on Total Capital	2.89	2.44	2.16	1.86	1.98
Return On Equity %	36.06	-31.14	-6.94	-24.09	10.84
Return on Common Equity	36.06	-31.14	-6.94	-24.09	10.84
Margin Analysis
Gross Profit Margin %	56.99	55.97	53.56	53.73	52.01
SG&A Margin	29.19	29.43	30.86	31.72	31.74
EBITDA Margin %	23.54	22.28	19.15	16.39	16.71
EBITA Margin %	19.93	18.26	14.58	11.31	11.23
EBIT Margin %	18.96	17.38	13.69	10.48	10.3
Income From Continuing Operations Margin %	145.28	-129.45	-23.86	-71.86	29.42
Net Income Margin %	145.28	-129.45	-23.86	-71.86	29.42
Net Avail. For Common Margin %	145.28	-129.45	-23.86	-71.86	29.42
Normalized Net Income Margin	12.17	11.19	10.05	7.49	7.72
Levered Free Cash Flow Margin	16.76	1.63	4.65	7.05	9.93
Unlevered Free Cash Flow Margin	16.8	2.48	5.81	8.24	11.12
Asset Turnover
Asset Turnover	0.19	0.18	0.21	0.24	0.26
Fixed Assets Turnover	4.21	4.01	3.81	3.63	3.69
Receivables Turnover (Average Receivables)	6.93	6.1	5.43	5.45	5.66
Inventory Turnover (Average Inventory)	2.1	1.91	1.65	1.54	1.65
Short Term Liquidity
Current Ratio	2.92	5.55	5.83	6.48	5.62
Quick Ratio	1.9	4.04	4.03	4.55	3.89
Operating Cash Flow to Current Liabilities	0.96	0.34	0.72	0.97	1.03
Days Sales Outstanding (Average Receivables)	52.64	59.8	67.2	67.13	64.51
Days Outstanding Inventory (Average Inventory)	173.44	191.04	220.67	237.38	220.94
Average Days Payable Outstanding	42.55	36.61	39.21	41.85	37.58
Cash Conversion Cycle (Average Days)	183.53	214.23	248.66	262.66	247.87
Long Term Solvency
Total Debt/Equity	1.63	14.44	16.08	20.93	18.58
Total Debt / Total Capital	1.61	12.62	13.85	17.3	15.67
LT Debt/Equity	1.36	14.05	15.61	20.27	18.08
Long-Term Debt / Total Capital	1.34	12.28	13.45	16.76	15.24
Total Liabilities / Total Assets	23.11	28.78	28.93	29.85	29.53
EBIT / Interest Expense	357.27	12.78	7.4	5.5	5.43
EBITDA / Interest Expense	475.91	17.81	11.63	10.02	10.17
(EBITDA - Capex) / Interest Expense	398.02	14.85	8.46	6.64	6.96
Total Debt / EBITDA	0.3	2.05	2.44	2.8	2.78
Net Debt / EBITDA	-0.88	-0.59	-0.35	-0.59	-0.31
Total Debt / (EBITDA - Capex)	0.36	2.45	3.36	4.24	4.06
Net Debt / (EBITDA - Capex)	-1.05	-0.71	-0.48	-0.89	-0.46
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	14.81	-4.12	-4.67	-3.92	0.65
Gross Profit, 1 Yr. Growth %	15.85	-5.69	-8.77	-3.36	-3.59
EBITDA, 1 Yr. Growth %	25.22	-11.16	-18.03	-13.05	-2.09
EBITA, 1 Yr. Growth %	32.77	-13.75	-23.88	-19.75	-6.57
EBIT, 1 Yr. Growth %	34.74	-13.83	-24.88	-20.37	-7.95
Earnings From Cont. Operations, 1 Yr. Growth %	11.55	-185.27	-82.43	189.38	-141.2
Net Income, 1 Yr. Growth %	11.55	-185.27	-82.43	189.38	-141.2
Normalized Net Income, 1 Yr. Growth %	40.97	-13.5	-14.42	-23.39	-3.16
Diluted EPS Before Extra, 1 Yr. Growth %	11.38	-186.48	-82.08	199.56	-142.61
Accounts Receivable, 1 Yr. Growth %	0.98	16.79	-1.14	-7.46	1.79
Inventory, 1 Yr. Growth %	-8.04	25.7	8.51	-2.63	-2.54
Net Property, Plant and Equip., 1 Yr. Growth %	0.32	-5.15	6.5	-4.85	3.09
Total Assets, 1 Yr. Growth %	37.03	-24.15	-8.91	-23.86	12.95
Tangible Book Value, 1 Yr. Growth %	39.17	-32.16	-9.8	-26.75	14.22
Common Equity, 1 Yr. Growth %	38.33	-29.74	-9.09	-24.85	13.46
Cash From Operations, 1 Yr. Growth %	14.11	-70.96	92.85	21.42	16.92
Capital Expenditures, 1 Yr. Growth %	22.12	-15.67	38.92	5.68	-4.83
Levered Free Cash Flow, 1 Yr. Growth %	24.45	-91.32	2.11T	69.27	32.59
Unlevered Free Cash Flow, 1 Yr. Growth %	20.52	-86.81	427.02	53.52	28.17
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.44	4.92	-4.4	-4.3	-1.66
Gross Profit, 2 Yr. CAGR %	15.11	4.44	-7.24	-6.2	-3.1
EBITDA, 2 Yr. CAGR %	37.5	5.58	-14.65	-17.63	-8.15
EBITA, 2 Yr. CAGR %	51.69	6.79	-18.96	-24.38	-13.71
EBIT, 2 Yr. CAGR %	55.33	7.5	-19.53	-25.34	-14.68
Earnings From Cont. Operations, 2 Yr. CAGR %	55.38	-2.48	-61.3	-28.7	9.2
Net Income, 2 Yr. CAGR %	55.38	-2.48	-61.3	-28.7	9.2
Normalized Net Income, 2 Yr. CAGR %	55.82	10.07	-13.96	-21.38	-13.81
Diluted EPS Before Extra, 2 Yr. CAGR %	55.31	-1.87	-60.64	-26.74	12.98
Accounts Receivable, 2 Yr. CAGR %	3.86	8.6	7.45	-4.36	-2.95
Inventory, 2 Yr. CAGR %	1.63	7.52	16.79	2.79	-2.58
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.39	-1.01	0.51	0.66	-0.96
Total Assets, 2 Yr. CAGR %	48.98	2.02	-16.87	-16.72	-7.27
Tangible Book Value, 2 Yr. CAGR %	56.34	-2.76	-21.77	-18.71	-8.53
Common Equity, 2 Yr. CAGR %	54.1	-1.35	-20.08	-17.34	-7.66
Cash From Operations, 2 Yr. CAGR %	19.74	-42.35	-25.17	53.02	19.15
Capital Expenditures, 2 Yr. CAGR %	10.73	1.92	8.23	21.16	0.29
Levered Free Cash Flow, 2 Yr. CAGR %	24.55	-67.36	-49.42	694.88	43.67
Unlevered Free Cash Flow, 2 Yr. CAGR %	21.88	-60.35	-43.54	181.53	36.05
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.48	6.63	1.62	-4.24	-2.68
Gross Profit, 3 Yr. CAGR %	10.72	7.66	-0.16	-6.06	-5
EBITDA, 3 Yr. CAGR %	27.57	19.71	-2.96	-15.71	-11.37
EBITA, 3 Yr. CAGR %	38.02	26.45	-4.62	-21.2	-17.02
EBIT, 3 Yr. CAGR %	42.06	28.47	-4.61	-21.9	-17.99
Earnings From Cont. Operations, 3 Yr. CAGR %	126.46	27.29	-44.92	-24.32	-40.61
Net Income, 3 Yr. CAGR %	126.46	27.29	-44.92	-24.32	-40.61
Normalized Net Income, 3 Yr. CAGR %	43.39	28.87	1.21	-19.06	-13.77
Diluted EPS Before Extra, 3 Yr. CAGR %	126.48	27.86	-44.33	-22.57	-38.85
Accounts Receivable, 3 Yr. CAGR %	2.57	8	5.25	2.23	-2.35
Inventory, 3 Yr. CAGR %	-0.67	9.09	7.85	9.92	0.98
Net Property, Plant and Equip., 3 Yr. CAGR %	11	-1.04	1.43	-1.31	1.47
Total Assets, 3 Yr. CAGR %	46.87	19.02	-1.76	-19.27	-7.82
Tangible Book Value, 3 Yr. CAGR %	52.73	18.42	-5.17	-23.47	-8.95
Common Equity, 3 Yr. CAGR %	50.36	18.66	-4	-21.7	-8.14
Cash From Operations, 3 Yr. CAGR %	31.99	-24.84	-13.78	-12.07	39.89
Capital Expenditures, 3 Yr. CAGR %	-2.37	4.61	13.01	7.38	11.79
Levered Free Cash Flow, 3 Yr. CAGR %	54.47	-47.54	-33.77	-28.07	347.52
Unlevered Free Cash Flow, 3 Yr. CAGR %	49.17	-40.55	-29.42	-24.28	120.81
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.16	5.34	3.13	2.11	0.29
Gross Profit, 5 Yr. CAGR %	7.87	5.68	3.12	1.87	-1.35
EBITDA, 5 Yr. CAGR %	18.7	15.7	9.07	2.94	-5.07
EBITA, 5 Yr. CAGR %	25.89	22.82	11.94	2.77	-8.36
EBIT, 5 Yr. CAGR %	30.04	26.16	13.6	3.21	-8.77
Earnings From Cont. Operations, 5 Yr. CAGR %	177.08	97	11.76	0.95	-27.58
Net Income, 5 Yr. CAGR %	177.08	97	11.76	0.95	-27.58
Normalized Net Income, 5 Yr. CAGR %	32.92	29.49	17.34	5.59	-5.08
Diluted EPS Before Extra, 5 Yr. CAGR %	175.85	97.33	12.52	2.32	-26.11
Accounts Receivable, 5 Yr. CAGR %	2.61	1.25	4.5	2.88	1.89
Inventory, 5 Yr. CAGR %	1.74	3.87	5.98	6.53	3.55
Net Property, Plant and Equip., 5 Yr. CAGR %	7.32	6.61	7.31	-0.36	0.47
Total Assets, 5 Yr. CAGR %	35.79	25.87	16.99	3.18	-4
Tangible Book Value, 5 Yr. CAGR %	46.44	31.59	16.9	1.87	-6.53
Common Equity, 5 Yr. CAGR %	39.59	26.83	16.8	2.68	-5.48
Cash From Operations, 5 Yr. CAGR %	24.89	13.3	5.6	-0.12	-1.87
Capital Expenditures, 5 Yr. CAGR %	-3.1	0.26	3.83	10.94	7.74
Levered Free Cash Flow, 5 Yr. CAGR %	33.25	-0.81	-1.33	-10.55	-9.72
Unlevered Free Cash Flow, 5 Yr. CAGR %	30.37	15.96	0.97	-8.54	-8.24